Cargando…
MiR-503逆转肺癌耐药细胞株A549/DDP的耐药性及其机制研究
BACKGROUND AND OBJECTIVE: Cisplatin-resistance in lung cancer cells is general in clinic, hence it is significant to investigate the mechanisms of cisplatin-resistant and develop new methods of reversing drug-resistance. Recent researches showed that miRNA could regulate cell growth, apoptosis, migr...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000201/ https://www.ncbi.nlm.nih.gov/pubmed/24398307 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.01.01 |
Ejemplares similares
-
异长春花碱逆转肺癌顺铂耐药A549/DDP细胞耐药性的作用和机制
Publicado: (2014) -
STE029逆转肺腺癌EGFR-TKI耐药及其机制研究
Publicado: (2022) -
人肺腺癌Anip973/NVB耐药细胞系动物模型的建立及其耐药机制的研究
Publicado: (2012) -
IKBKB在人肺腺癌细胞株A549及其耐药细胞株A549/DDP中的表达和意义
Publicado: (2014) -
下调βⅢ-tubulin逆转肺腺癌A549/Taxol细胞株紫杉醇耐药
Publicado: (2014)